Clinical trial NCT01193764: Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris
Official title: Double Blind Placebo Controlled Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: NA
Conditions: Acne
Keywords: acne
cocoa
chocolate
gelatin
pustule
comedones
papules
pustules
Lead sponsor: University of Miami
Sponsor class: OTHER
First posted: 2010-09-02
Enrollment: 14
Sex: MALE
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: DIAGNOSTIC

Brief summary: The investigators conducted a recent pilot study and found a strong positive correlation between the consumption of 100% chocolate and acne exacerbation. However, this study had limitations including the lack of placebo and the small sample size. Although studies have been conducted assessing chocolate's effect on acne, no study has been done evaluating this effect using chocolate with 100% cocoa content in a double blind placebo controlled fashion. This study will analyze the difference in the number and type of acneiform lesions per subject at the different time points (Day 4 and Day 7) compared to baseline in order to increase the validity of the investigators results. In addition, the investigators will use unsweetened cocoa powder,12 rather than chocolate candy, which contains higher quantities of additive ingredients such as sugar and milk to avoid interference with the results and the possibility to establish or not an association between the unsweetened cocoa and an effect on acne.


Eligibility criteria: Inclusion Criteria:

* Post-pubescent males between the ages of 18-35 with minimal facial acne lesions defined as no less than 1 comedone and/or papule and no more than 8 total comedones and papules at Screening/Baseline
* Subjects who have no more than 2 papules at baseline
* Subjects who have no facial pustules at Screening/Baseline
* Subjects who have a history of facial acne vulgaris
* Subjects with a score of 0 or 1 on the investigator's Global Assessment Scale (See Appendix A)
* Subjects must sign an informed consent form
* Subjects must remain in the South Florida area during the study
* Volunteers in general good health
* Volunteers on no over the counter or prescribed medication, including supplements
* Subjects must be literate in the English language

Exclusion Criteria:

* Subjects of the female gender
* Subjects with a history of diabetes mellitus
* Subjects who have had allergic reactions to cocoa or gelatin
* Subjects who have more than 8 total comedones and papules at Screening/Baseline
* Subjects who have more than 2 papules at screening/baseline
* Subjects who have one or more pustules and/or nodules at Screening/Baseline
* Subjects with a history of taking anti-acne oral medication (i.e. isotretinoine) during the past six months
* Subjects who have used any oral antibiotics in the past two weeks
* Subjects currently applying any over-the-counter or prescribed anti-acne medication including, but not limited to, retinoic acid or benzoyl peroxide over the past six weeks
* Subjects who have used facial topical or injectable steroids 6 weeks prior to screening/baseline and during the study
* Subjects currently taking any over-the-counter or prescribed medication including but not limited to oral supplements, vitamin A, etc. over the past two weeks
* Subjects who used systemic corticosteroids 6 weeks prior to screening/baseline or during the study
* Subjects taking drugs known to be photosensitizers including, but not limited to, phenothiazines, amiodarone, quinine, thiazides, tetracyclines, sulphonamides, quinolones
* Subjects who are expected to have excess sun exposure during the study
* Subjects who will not be in the South Florida area during the study
* Subjects who are diagnosed with obesity with a BMI of 30 or greater
* Subjects who have a history of hypertriglyceridemia

Primary outcomes:
measure: Number of acneiform lesions
timeFrame: 7 days
Secondary outcomes:
Other outcomes:
Locations:
city: Miami
country: United States
facility: University of Miami
state: Florida
Study officials:
affiliation: University of Miami
name: Samantha Block, B.S.
role: STUDY_DIRECTOR
affiliation: University of Miami
name: Brian Berman, M.D., Ph.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Miami
name: Caroline Caperton, M.D., M.S.P.H.
role: STUDY_CHAIR
affiliation: University of Miami
name: Whitney Valins, B.S.
role: STUDY_CHAIR
References: